AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2005
Nov 1, 2005
33510_dirs_2005-11-01_f0cd2341-3efa-4479-b490-75e4277e038e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISRY)
CIK: 0000728387
Period of Report: 2005-10-28
Reporting Person: Swanberg David (Director, V.P. Operations & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-10-28 | Common Stock | P | 12500 | $4 | Acquired | 297109 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-10-28 | Common Stock Purchase Warrant | $6 | P | 12500 | Acquired | 2007-10-28 | Common Stock (12500) | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16